(Q37439512)

20 August 2017

Pharmacokinetics and 48-week safety and antiviral activity of fosamprenavir-containing regimens in HIV-infected 2- to 18-year-old children (English)

1 reference

20 August 2017

1 reference

ChEBI release 2020-05-28

4

Harmony P Garges

1 reference

20 August 2017

Claudia Fortuny

1

1 reference

20 August 2017

Dan Duiculescu

2

1 reference

20 August 2017

Katharine Cheng

3

1 reference

20 August 2017

Mark Cotton

5

1 reference

20 August 2017

Desamparados Pérez Tamarirt

6

1 reference

20 August 2017

Susan L Ford

7

1 reference

20 August 2017

Mary Beth Wire

8

1 reference

20 August 2017

Naomi Givens

9

1 reference

20 August 2017

Lisa L Ross

10

1 reference

20 August 2017

Yu Lou

11

1 reference

20 August 2017

Teodora Perger

12

1 reference

20 August 2017

Jörg Sievers

13

1 reference

20 August 2017

1 January 2014

1 reference

Pediatric Infectious Disease Journal

20 August 2017

1 reference

20 August 2017

33

1 reference

20 August 2017

50-56

1 reference

20 August 2017

1

1 reference

Recent advances in pharmacovigilance of antiretroviral therapy in HIV-infected and exposed children

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882305

Update of the drug resistance mutations in HIV-1: December 2010.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882305

PENTA 2009 guidelines for the use of antiretroviral therapy in paediatric HIV-1 infection

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882305

Early Antiretroviral Therapy and Mortality among HIV-Infected Infants

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882305

Fosamprenavir calcium plus ritonavir for HIV infection

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882305

The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882305

Long-term efficacy and safety of fosamprenavir in human immunodeficiency virus-infected pediatric patients

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882305

Pharmacokinetic and pharmacodynamic analysis of amprenavir-containing combination therapy in HIV-1-infected children

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882305

SOLO: 48-week efficacy and safety comparison of once-daily fosamprenavir /ritonavir versus twice-daily nelfinavir in naive HIV-1-infected patients

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882305

The NEAT study: a 48-week open-label study to compare the antiviral efficacy and safety of GW433908 versus nelfinavir in antiretroviral therapy-naive HIV-1-infected patients

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882305

Forty-eight-week evaluation of lopinavir/ritonavir, a new protease inhibitor, in human immunodeficiency virus-infected children

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882305

Effect of Combination Therapy Including Protease Inhibitors on Mortality among Children and Adolescents Infected with HIV-1

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882305

Nucleoside analogs plus ritonavir in stable antiretroviral therapy-experienced HIV-infected children: a randomized controlled trial. Pediatric AIDS Clinical Trials Group 338 Study Team

3 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23811744

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1097/INF.0B013E3182A1126A

1 reference

20 August 2017

1 reference

20 August 2017

1 reference